NO20030627L - Hydrogel-drevet medikament doseringsform - Google Patents

Hydrogel-drevet medikament doseringsform

Info

Publication number
NO20030627L
NO20030627L NO20030627A NO20030627A NO20030627L NO 20030627 L NO20030627 L NO 20030627L NO 20030627 A NO20030627 A NO 20030627A NO 20030627 A NO20030627 A NO 20030627A NO 20030627 L NO20030627 L NO 20030627L
Authority
NO
Norway
Prior art keywords
hydrogel
dosage form
drug dosage
driven drug
driven
Prior art date
Application number
NO20030627A
Other languages
English (en)
Other versions
NO20030627D0 (no
Inventor
Leah Elizabeth Appel
Walter Christian Babcock
Ronald Arthur Beyerinck
Mark Brian Chidlaw
William John Curatolo
Dwayne Thomas Friesen
Scott Max Herbig
Avinash Govind Thombre
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO20030627D0 publication Critical patent/NO20030627D0/no
Publication of NO20030627L publication Critical patent/NO20030627L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20030627A 2000-08-09 2003-02-07 Hydrogel-drevet medikament doseringsform NO20030627L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22419900P 2000-08-09 2000-08-09
PCT/IB2001/001390 WO2002011702A2 (en) 2000-08-09 2001-08-03 Hydrogel-driven drug dosage form

Publications (2)

Publication Number Publication Date
NO20030627D0 NO20030627D0 (no) 2003-02-07
NO20030627L true NO20030627L (no) 2003-04-08

Family

ID=22839665

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030627A NO20030627L (no) 2000-08-09 2003-02-07 Hydrogel-drevet medikament doseringsform

Country Status (30)

Country Link
US (2) US20030086972A1 (no)
EP (1) EP1326587A2 (no)
JP (1) JP2004505907A (no)
KR (1) KR20030024844A (no)
CN (1) CN1461212A (no)
AP (1) AP2001002237A0 (no)
AU (1) AU2002229141A1 (no)
BG (1) BG107538A (no)
BR (1) BR0113067A (no)
CA (1) CA2418907A1 (no)
DO (1) DOP2001000229A (no)
EA (1) EA200300081A1 (no)
EC (1) ECSP034455A (no)
EE (1) EE200300055A (no)
GT (1) GT200100161A (no)
HR (1) HRP20030082A2 (no)
HU (1) HUP0300722A2 (no)
IL (1) IL154012A0 (no)
IS (1) IS6686A (no)
MA (1) MA26939A1 (no)
MX (1) MXPA03001209A (no)
NO (1) NO20030627L (no)
OA (1) OA12365A (no)
PA (1) PA8524901A1 (no)
PE (1) PE20020307A1 (no)
PL (1) PL360658A1 (no)
SV (1) SV2002000586A (no)
TN (1) TNSN01123A1 (no)
UY (1) UY26876A1 (no)
WO (1) WO2002011702A2 (no)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0957073A1 (en) 1998-05-12 1999-11-17 Schwarz Pharma Ag Novel derivatives of 3,3-diphenylpropylamines
AP2002002553A0 (en) * 1999-12-23 2002-06-30 Pfizer Prod Inc Hydrogel-driven Drug Dosoge Form.
AR030557A1 (es) 2000-04-14 2003-08-27 Jagotec Ag Una tableta en multicapa de liberacion controlada y metodo de tratamiento
EP1738751B1 (en) 2001-01-12 2011-05-11 Sun Pharma Advanced Research Company Ltd Spaced drug delivery system
NZ532097A (en) 2001-09-28 2006-02-24 Mcneil Ppc Inc Dosage forms having an inner core and outer shell
WO2003096968A2 (en) * 2002-05-15 2003-11-27 Sun Pharmaceutical Industries Limited Oral osmotic controlled drug delivery system
US9060941B2 (en) 2002-09-20 2015-06-23 Actavis, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US8084058B2 (en) 2002-09-20 2011-12-27 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
ES2529180T3 (es) * 2002-09-20 2015-02-17 Andrx Labs Llc Formulación multietapa que contiene una biguanida y un derivado de tiazolidinodiona
US7959946B2 (en) 2002-09-20 2011-06-14 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7785627B2 (en) 2002-09-20 2010-08-31 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7807197B2 (en) 2002-09-28 2010-10-05 Mcneil-Ppc, Inc. Composite dosage forms having an inlaid portion
RU2005108611A (ru) * 2002-09-28 2005-09-20 МакНЕЙЛ-ППС, ИНК. (US) Дозированные формы модифицированного высвобождения с двумя ядрами
FR2850576B1 (fr) * 2003-02-05 2007-03-23 Ethypharm Sa Composition comprenant un melange de principes actifs, et procede de preparation
US20060210633A1 (en) * 2003-04-03 2006-09-21 Sun Pharmaceutical Industries Limited Programmed drug delivery system
DE10315917A1 (de) * 2003-04-08 2004-11-18 Schwarz Pharma Ag Hochreine Basen von 3,3-Diphenylpropylaminmonoestern
AR040157A1 (es) * 2003-06-06 2005-03-16 Rodriguez Julio Cesar Una formulacion en microgranulos para administracion oral en suspension acuosa
KR20060033033A (ko) * 2003-08-04 2006-04-18 화이자 프로덕츠 인크. 콜레스테릴 에스테르 전달 단백질 억제제의 제어 방출 및ｈｍｇ-ｃｏａ 리덕타제 억제제의 순간 방출을 제공하는제형
US7879354B2 (en) 2004-01-13 2011-02-01 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
US8067029B2 (en) 2004-01-13 2011-11-29 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
WO2006082500A1 (en) * 2005-02-03 2006-08-10 Pfizer Products Inc. Dosage forms providing controlled and immediate release of cholesteryl ester transfer protein inhibitors and immediate release of hmg-coa reductase inhibitors
US20060228413A1 (en) * 2005-02-28 2006-10-12 Penwest Pharmaceuticals Co. Controlled release venlafaxine formulations
JP5020931B2 (ja) * 2005-03-14 2012-09-05 サン・ファーマ・アドバンスド・リサーチ・カンパニー・リミテッド 経口薬剤送達システム
US20080187581A1 (en) * 2005-03-16 2008-08-07 Subhash Pandurang Gore Delivery System For Mulitple Drugs
US8673352B2 (en) 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
CN100448433C (zh) * 2005-09-21 2009-01-07 广州贝氏药业有限公司 一种克拉霉素肠溶药物组合物
WO2007124372A2 (en) * 2006-04-20 2007-11-01 Transport Pharmaceuticals, Inc. Pharmaceutical formulations for iontophoretic methotrexate delivery
SA07280459B1 (ar) * 2006-08-25 2011-07-20 بيورديو فارما إل. بي. أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
KR20080076382A (ko) * 2007-02-15 2008-08-20 (주)아모레퍼시픽 실로스타졸의 제어방출 제제 및 그 제조방법
EP2242485A4 (en) * 2008-02-15 2013-05-08 Sun Pharma Advanced Res Co Ltd ORAL TABLET WITH CONTROLLED RELEASE
EA201290315A1 (ru) * 2009-11-09 2012-10-30 Кэпсьюджел Белджиум Нв Носитель для доставки
WO2011115067A1 (ja) 2010-03-19 2011-09-22 第一三共株式会社 抗凝固剤の溶出改善方法
TWI578988B (zh) 2011-08-10 2017-04-21 第一三共股份有限公司 含二胺衍生物之醫藥組成物
KR101644837B1 (ko) * 2013-01-30 2016-08-03 주식회사 대웅 위장관 내 상처 보호, 출혈 방지, 또는 유착 방지용 약학 조성물
MA41868A (fr) * 2015-04-01 2018-02-06 Spectrum Brands Inc Pastille retard et procédés s'y rapportant
CN111867562B (zh) * 2018-03-07 2023-07-07 陈献 不溶性药物的水性制剂
AU2022280939A1 (en) * 2021-05-28 2023-10-05 Amgen Inc. Formulations of apremilast
CN113600179B (zh) * 2021-09-16 2023-07-04 山东博霖环保科技发展有限公司 一种脱硝催化剂及其制备方法
JPWO2023063381A1 (no) * 2021-10-14 2023-04-20

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1025765B (it) * 1974-11-18 1978-08-30 Gastaldi Francesco Essiccatore perfezionato a spruzzo
US4187617A (en) * 1978-12-18 1980-02-12 Becker James J Jr Spray dryer
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4449983A (en) * 1982-03-22 1984-05-22 Alza Corporation Simultaneous delivery of two drugs from unit delivery device
US4612008A (en) * 1983-05-11 1986-09-16 Alza Corporation Osmotic device with dual thermodynamic activity
US4624848A (en) * 1984-05-10 1986-11-25 Ciba-Geigy Corporation Active agent containing hydrogel devices wherein the active agent concentration profile contains a sigmoidal concentration gradient for improved constant release, their manufacture and use
US4851232A (en) * 1987-02-13 1989-07-25 Alza Corporation Drug delivery system with means for obtaining desirable in vivo release rate pattern
GB8820353D0 (en) * 1988-08-26 1988-09-28 Staniforth J N Controlled release tablet
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
US5096716A (en) * 1988-09-01 1992-03-17 Alza Corporation Dosage form for administering calcium antagonist nicardipine
US5030452A (en) * 1989-01-12 1991-07-09 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Hydrogel-operated release devices
US5120548A (en) * 1989-11-07 1992-06-09 Merck & Co., Inc. Swelling modulated polymeric drug delivery device
JPH05178763A (ja) * 1991-02-19 1993-07-20 Nippon Saafuakutanto Kogyo Kk 難溶解性薬物溶解剤組成物
SK282854B6 (sk) * 1994-05-06 2002-12-03 Pfizer Inc. Dávkovacia forma s riadeným uvoľňovaním obsahujúca azitromycín
US5654005A (en) * 1995-06-07 1997-08-05 Andrx Pharmaceuticals, Inc. Controlled release formulation having a preformed passageway
TW487582B (en) * 1995-08-11 2002-05-21 Nissan Chemical Ind Ltd Method for converting sparingly water-soluble medical substance to amorphous state
IL152330A0 (en) * 1997-07-01 2003-05-29 Pfizer Sertraline salts and sustained-release dosage forms of sertraline
CN1261794A (zh) * 1997-07-01 2000-08-02 辉瑞产品公司 增溶的舍曲林组合物
DE19747261A1 (de) * 1997-10-25 1999-04-29 Bayer Ag Osmotisches Arzneimittelfreisetzungssystem
US6037346A (en) * 1997-10-28 2000-03-14 Vivus, Inc. Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
SK4582001A3 (en) * 1998-10-13 2002-02-05 Pfizer Prod Inc Sertraline oral concentrate
EP1027888B1 (en) * 1999-02-10 2009-06-10 Pfizer Products Inc. Osmotic system for delivery of solid amorphous dispersions of drugs
US6500459B1 (en) * 1999-07-21 2002-12-31 Harinderpal Chhabra Controlled onset and sustained release dosage forms and the preparation thereof
GT200100039A (es) * 2000-03-16 2001-12-31 Pfizer Inhibidor de la glucogeno fosforilasa.
JP2006510655A (ja) * 2002-12-11 2006-03-30 ファイザー・プロダクツ・インク 高脂肪環境への活性物質の制御放出

Also Published As

Publication number Publication date
ECSP034455A (es) 2003-03-10
DOP2001000229A (es) 2002-09-30
SV2002000586A (es) 2002-10-24
NO20030627D0 (no) 2003-02-07
KR20030024844A (ko) 2003-03-26
GT200100161A (es) 2002-03-22
BR0113067A (pt) 2003-07-01
JP2004505907A (ja) 2004-02-26
PA8524901A1 (es) 2002-04-25
IL154012A0 (en) 2003-07-31
WO2002011702A2 (en) 2002-02-14
UY26876A1 (es) 2002-03-22
CA2418907A1 (en) 2002-02-14
EA200300081A1 (ru) 2003-08-28
EP1326587A2 (en) 2003-07-16
EE200300055A (et) 2004-12-15
PE20020307A1 (es) 2002-04-23
HRP20030082A2 (en) 2003-04-30
MXPA03001209A (es) 2003-06-30
PL360658A1 (en) 2004-09-20
AP2001002237A0 (en) 2001-09-30
CN1461212A (zh) 2003-12-10
TNSN01123A1 (fr) 2005-11-10
WO2002011702A3 (en) 2002-11-28
AU2002229141A1 (en) 2002-02-18
MA26939A1 (fr) 2004-12-20
IS6686A (is) 2003-01-16
OA12365A (en) 2006-05-16
US20030086972A1 (en) 2003-05-08
HUP0300722A2 (hu) 2003-11-28
US20040052845A1 (en) 2004-03-18
BG107538A (bg) 2003-11-28

Similar Documents

Publication Publication Date Title
NO20030627L (no) Hydrogel-drevet medikament doseringsform
NO20022970D0 (no) Hydrogel-drevet medikamentdoseringsform
ITTO20010008A0 (it) Formulazione farmaceutica
ATE355271T1 (de) Pharmazeutische zusammensetzung
ATE311915T1 (de) Medikamentenspender
EE200000497A (et) Kiiresti lahustuv peroraalne ravimvorm
DK1204410T3 (da) Farmaceutisk doseringsform med flere komponenter
NO20071303L (no) Farmasoytiske preparater
AR028204A1 (es) Composiciones farmaceuticas electrohiladas
NO20030418D0 (no) Nytt farmasöytisk preparat
EE200300416A (et) Ravimvorm
ITMI20010748A0 (it) Composizioni farmaceutiche
MXPA03001425A (es) Compuestos farmaceuticos.
NO20026123L (no) Farmasöytiske sammensetninger
DE50102752D1 (de) Fungizide wirkstoffkombinationen
DE60129238D1 (de) Pharmazeutische zusammensetzung
NO20032957L (no) Farmasöytisk emulsjonspreparat
EE200200689A (et) Ravimkoostised
SE0004677D0 (sv) Intraaxonal läkemedelsadministration
IL134581A0 (en) Pharmaceutical dosage form
SE0102823D0 (sv) New drug
DK1221918T3 (da) Sub-tenon lægemiddellevering

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application